SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-22-000994
Filing Date
2022-03-08
Accepted
2022-03-08 08:30:55
Documents
65
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 zk2227416.htm   iXBRL 10-K 2310174
2 EXHIBIT 21.1 exhibit_21-1.htm EX-21.1 3130
3 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 3007
4 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 12314
5 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 12585
6 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 4550
7 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 4525
13 GRAPHIC entx_img01.jpg GRAPHIC 97606
14 GRAPHIC entx_img02.jpg GRAPHIC 55807
  Complete submission text file 0001178913-22-000994.txt   8458393

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE entx-20211231.xsd EX-101.SCH 53562
9 XBRL CALCULATION FILE entx-20211231_cal.xml EX-101.CAL 33766
10 XBRL DEFINITION FILE entx-20211231_def.xml EX-101.DEF 151599
11 XBRL LABEL FILE entx-20211231_lab.xml EX-101.LAB 727146
12 XBRL PRESENTATION FILE entx-20211231_pre.xml EX-101.PRE 295675
59 EXTRACTED XBRL INSTANCE DOCUMENT zk2227416_htm.xml XML 1276401
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38556 | Film No.: 22720409
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences